Cash-rich Citizen Watch to buy back up to 25% of shares
TOKYO -- Citizen Watch will repurchase up to 25.61% of its outstanding shares under plans announced Monday, aiming to improve returns after logging record profits in the April-December period. Buying back up to 75 million shares will cost as much as 40 billion yen ($301 million). This will be the…#tokyo #citizenwatch
Source: Reuters: Health - February 13, 2023 Category: Consumer Health News Source Type: news

Prognostic factors for persistent fatigue after COVID-19: a prospective matched cohort study in primary care
Study (n=301) found persistent fatigue more common in suspected COVID-19 pts vs non-suspected (35% v 13%; OR 3.65 95% CI 1.82-7.32). Prognostic factors included low education, partner absence, high neuroticism, low resilience, high GP contact, and medication use.
Source: Current Awareness Service for Health (CASH) - February 8, 2023 Category: Consumer Health News Source Type: news

U.S. must address IP and market access barriers abroad to protect American innovation
PhRMA recentlysubmitted comments to the Office of the U.S. Trade Representative (USTR) ’s 2023 Special 301 Report. The comments highlight foreign government actions and policies that undermine American innovation, biopharmaceutical leadership and more than 4.4 millionAmerican jobs.  
Source: The Catalyst - January 31, 2023 Category: Pharmaceuticals Authors: Ernest Kawka Tags: Intellectual Property Coronavirus TRIPS Waiver Source Type: news

NFT Collection Gutter Species Mint Pass Price, Stats, and Review
The total number of owners has reached 67. NFT Collection Gutter Species Mint Pass Price and Sales The market capitalization of Gutter Species Mint Pass NFT collection is 0 ETH. For all time, 3,301 collections sales were made at an average price of 1.27 ETH (~$1,951.17 at the time of writing).…#gutterspeciesmint #weth #buyer
Source: Reuters: Health - January 19, 2023 Category: Consumer Health News Source Type: news

PBoC sells 301 bln yuan of 14-day reverse repo at a yield of 2.15%
Source: Reuters: Health - January 17, 2023 Category: Consumer Health News Source Type: news

Cost-of-living payments: Three instalments totalling £900 confirmed
The first payment of £301 will be made in the spring, with a second of £300 in the autumn and a final £299 instalment in the spring of 2024. Charities have called on the government to do more to protect vulnerable households from soaring costs, claiming that support had not improved for those…#myronjobson #simonfrancis #energybillssupport #melstride #interactiveinvestor
Source: Reuters: Health - January 3, 2023 Category: Consumer Health News Source Type: news

TSA has stopped record number of guns at airport security checkpoints in 2022
Authorities have stopped more than 6,000 firearms from going through airport security checkpoints so far this year, the most in the history of the Transportation Security Administration, officials said. Of the 6,301 guns discovered by officers at checkpoints, more than 88% were loaded. “TSA…#davidpekoske #tsa #martinelam #firearm #elam #lax #precheck
Source: Reuters: Health - December 31, 2022 Category: Consumer Health News Source Type: news

TSA finds record number of firearms at security checkpoints in 2022
Transportation Security Administration officers intercepted a record number of firearms brought by passengers to airport security checkpoints in 2022, the agency said Friday. Driving the news: TSA has stopped 6,301 firearms so far this year — more than 88% of which were loaded. By the numbers:…#davidpekoske #transportationsecurityadministration #tsa
Source: Reuters: Health - December 17, 2022 Category: Consumer Health News Source Type: news

Improving injury surveillance data quality in Victoria through emergency department engagement conference abstract #301 - Sheppard D, Hayman J, Allen T, Berecki-Gisolf J.
We describe baseline and preliminary follow-up data of a study aimed at improving injury surveillance data quality of hospitals contributing to the ...
Source: SafetyLit - December 1, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

DriveNet (Bitcoin Core + Bip300 & 301) Version 44 has been released
Source: Reuters: Health - November 23, 2022 Category: Consumer Health News Source Type: news

Live results for Question 300, Issue 301: Allowing, taxing recreational cannabis in Colorado Springs
Find updates and results for Colorado Springs' Question 300, Issue 301. #coloradosprings
Source: Reuters: Health - November 9, 2022 Category: Consumer Health News Source Type: news

Risk factors for the presence and persistence of posttraumatic stress symptoms following traumatic brain injury in U.S. service members and veterans - Lange RT, French LM, Lippa S, Baschenis SM, Gillow KC, Glazer ME, Rogers AA, Cristaudo KE, Bailie JM, Hungerford L, Kennedy J, Brickell TA.
This study aimed to identify risk factors predictive of the presence and persistence of posttraumatic stress disorder (PTSD) symptom reporting following traumatic brain injury (TBI). Participants were 1,301 U.S. service members and veterans (SMVs) divided ...
Source: SafetyLit - November 2, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Through Four Years in Adults with Moderately to Severely Active Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final data from the long-term extension (LTE) of the Phase 3 UNIFI study demonstrating efficacy and safety of STELARA® (ustekinumab) through four years of treatment in adult patients with moderately to severely active ulcerative colitis (UC).1 Among all patients who had achieved clinical responsea with STELARA during induction, 64.9 percent were in symptomatic remissionb after 44 weeks of maintenance. At week 200 (four years), this proportion of patients was 55.2 percent; the majority (96.4 percen...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news

Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion
Tarcocimab tedromer (KSI-301) dosed every two months met the primary endpoint of non-inferior visual acuity gains compared to aflibercept dosed every month First anti-VEGF therapy to achieve non-inferiority in visual acuity gains while doubling the trea... Biopharmaceuticals, Ophthalmology Kodiak Sciences, tarcocimab tedromer, retinal vein occlusion
Source: HSMN NewsFeed - August 8, 2022 Category: Pharmaceuticals Source Type: news

Nigeria: Monkeypox - Borno Confirms Four Infections, As Nigeria's Cases Surpass 100 in 2022
[Premium Times] Apart from the confirmed cases, NCDC stated in the situation report that no fewer than 301 suspected cases of the disease have been reported in the country.
Source: AllAfrica News: Health and Medicine - July 19, 2022 Category: African Health Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20